Trading & Momentum
Two Final Events Hold the Key for Sellas Life Sciences as the Stock Races Ahead of Its Fundamentals
Sellas Life Sciences has turned into a live referendum on a single clinical dataset, with the stock’s eye-popping 594% annual...
Ondas Holdings: Record Orders Fail to Lift Stock from Six-Month Lows as Dilution Overhang Weighs
Ondas Holdings racked up over $150 million in new orders during the second quarter, including $40 million in June alone,...
Antimony Resources: A Geopolitical Bet Gets a Geological Boost
The antimony market has been anything but ordinary since Beijing imposed export restrictions on the critical mineral, sending prices hurtling...
Realbotix Faces a Pivotal Gamble: Nasdaq Listing Hinges on Supply Chain and Shareholder Approval
Realbotix is navigating one of the most volatile stretches in its short public history as it pursues a high-stakes reverse...
ImmunityBio’s 369% Surge Meets 13% Short Interest — A Collision Course in Biotech
ImmunityBio has become a battleground stock where two opposing forces are digging in. Retail traders have piled into the biotech...
The $27 Billion Question: Can Micron’s Capacity Splurge Fend Off Burry’s Bear Thesis and SK Hynix’s Nasdaq Debut?
Record quarterly numbers. A stock that has tripled in 2025. And yet Micron Technology finds itself under siege from two...
Nokia’s AI Data Center Push in Cambodia and Laos Clashes With a 22% Monthly Stock Slide Ahead of Earnings
Nokia is accelerating its transformation into an artificial-intelligence infrastructure specialist, forging a new partnership in Southeast Asia and expanding chip...
Sivers Semiconductors Surges 16% as €62M Capital Raise Eases Dilution Fears, But Nasdaq Listing Remains in Limbo
The Swedish photonics and wireless chip specialist staged a sharp recovery on Friday, with shares climbing as much as 16...
Volkswagen’s July Crossroads: A Technical Rebound Meets a 100,000-Job Standoff
Volkswagen’s preferred shares clawed back more than 3% on Thursday to settle at €72.74, snapping a brutal slide that had...
IBM’s Human Talent Pivot Gains Momentum Alongside a 0.7nm Chip Breakthrough and $11B Quantum Ambition
IBM is rewriting its narrative. After years of touting artificial intelligence as the ultimate cost-cutting tool — and slashing entry-level...
Popular News
-
SunHydrogen Set for European Debut with Groundbreaking Technology
-
Walgreens Implements Deep Restructuring Following Private Buyout
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Trade Desk Shares Face Mounting Pressure as Tariff Warnings Materialize
-
Kraft Heinz Stock: A Contradiction in Market Sentiment
